World-renowned physician, Dr. Michael Roizen, MD, continues to update your understanding of the meaning of health by providing an in-depth review of the most impactful health headlines. He discusses the health news that matters most to you.
Dr. Roizen is later joined by Dr. Mark Rasenick, professor of physiology and biophysics at the University of Illinois.
Dr. Rasenick discusses his visits to Cuba and promising new medical treatments.
Bonus!
Real Age Tip
Nationwide Salmonella Outbreak Tied to Imported Cucumbers
Selected Podcast
Hour 1: YOU The Owner's Manual Radio 9.19.15
Featuring:
Dr. Mark Rasenick is distinguished professor of physiology and biophysics and psychiatry. He is founding director of the Neuroscience Program in the UIC College of Medicine. He has made significant contributions towards advancing the understanding of neurotransmitter signaling and the biology of mood disorders.
His research has helped identify a membrane protein, the localization of which can be used as a biomarker for depression. Using the biomarker as the basis of a blood test, Rasenick can accurately test for depression and assess the efficacy of antidepressant medications within just a few days of treatment — long before patients typically feel any beneficial effects. The test could lead to safer and more accurate therapeutic approaches. Rasenick has made more numerous trips to Cuba over the last two decades for scientific exchange meetings and to collaborate with Cuban researchers.
In April, 2014, he visited Cuba as part of a delegation of members of the American Association for the Advancement of Sciences to meet with leaders with the Cuban Academy of Science. The meeting resulted in the signing of a landmark agreement to advance scientific cooperation by Cuban and U.S. scientists, in key areas of mutual interest to both countries.
Mark M. Rasenick, PhD
Dr. Mark Rasenick is distinguished professor of physiology and biophysics and psychiatry. He is founding director of the Neuroscience Program in the UIC College of Medicine. He has made significant contributions towards advancing the understanding of neurotransmitter signaling and the biology of mood disorders. His research has helped identify a membrane protein, the localization of which can be used as a biomarker for depression. Using the biomarker as the basis of a blood test, Rasenick can accurately test for depression and assess the efficacy of antidepressant medications within just a few days of treatment — long before patients typically feel any beneficial effects. The test could lead to safer and more accurate therapeutic approaches. Rasenick has made more numerous trips to Cuba over the last two decades for scientific exchange meetings and to collaborate with Cuban researchers.
In April, 2014, he visited Cuba as part of a delegation of members of the American Association for the Advancement of Sciences to meet with leaders with the Cuban Academy of Science. The meeting resulted in the signing of a landmark agreement to advance scientific cooperation by Cuban and U.S. scientists, in key areas of mutual interest to both countries.